Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q2 2025 vs. Q1 2025
How the institutions holding Mesoblast Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 68 | 1 | 72 | +5 |
| Shares | 3.95M | 2.25K | 3.38M | −561.8K (−14.2%) |
| Value | $49.2M | $28.1K | $36.8M | −$12.4M (−25.2%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Mesoblast Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 33,213 | $361.7K | 0.00% |
| Verition Fund Management LLC | 28,844 | $314.1K | 0.00% |
| 49 Wealth Management, LLC | 17,829 | $194.2K | 0.02% |
| AQR Capital Management LLC | 13,932 | $151.7K | 0.00% |
| Creative Planning | 12,964 | $141.2K | 0.00% |
| R Squared Ltd | 11,571 | $126.0K | 0.07% |
| Ballentine Partners, LLC | 11,414 | $124.3K | 0.00% |
| Cantor Fitzgerald, L. P. | 10,147 | $110.5K | 0.00% |
| Raymond James Financial Inc | 7,892 | $85.9K | 0.00% |
| Deutsche Bank AG | 1,402 | $15.3K | 0.00% |
| Jones Financial Companies LLLP | 300 | $3.28K | 0.00% |
| MAI Capital Management | 223 | $2.43K | 0.00% |
| Allworth Financial LP | 145 | $1.58K | 0.00% |
| WealthCollab, LLC | 73 | $795 | 0.00% |
| UMA Financial Services, Inc. | 57 | $621 | 0.00% |
| Strengthening Families & Communities, LLC | 10 | $125 | 0.00% |
Sold out (11)
Institutions that held Mesoblast Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Toronto Dominion Bank | 150,000 | $1.87M |
| Jane Street Group, LLC | 48,601 | $606.5K |
| XY Capital Ltd | 27,755 | $346.4K |
| Thoroughbred Financial Services, LLC | 20,718 | $258.0K |
| Clayton Financial Group LLC | 13,893 | $173.4K |
| Old Mission Capital LLC | 11,848 | $147.9K |
| Sageworth Trust Co | 10,000 | $124.8K |
| Quadrant Capital Group LLC | 6,532 | $81.5K |
| Advisors Preferred, LLC | 4,578 | $54.5K |
| Point72 Asset Management, L.P. | 1,066 | $13.3K |
| SJS Investment Consulting Inc. | 48 | $600 |
Not filed for Q2 2025 yet (1)
Institutions that held Mesoblast Ltd at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 2,253 | $28.1K |